Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares
- 1 October 2002
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 25 (5), 343-350
- https://doi.org/10.1046/j.1365-2885.2002.00434.x
Abstract
Enrofloxacin was administered i.v. to five adult mares at a dose of 5 mg/kg. After administration, blood and endometrial biopsy samples were collected at regular intervals for 24 h. The plasma and tissue samples were analyzed for enrofloxacin and the metabolite ciprofloxacin by high‐pressure liquid chromatography. In plasma, enrofloxacin had a terminal half‐life (t½), volume of distribution (area method), and systemic clearance of 6.7 ± 2.9 h, 1.9 ± 0.4 L/kg, and 3.7 ± 1.4 mL/kg/min, respectively. Ciprofloxacin had a maximum plasma concentration (Cmax) of 0.28 ± 0.09 μg/mL. In endometrial tissue, the enrofloxacin Cmax was 1.7 ± 0.5 μg/g, and the t½ was 7.8 ± 3.7 h. Ciprofloxacin Cmax in tissues was 0.15 ± 0.04 μg/g and the t½ was 5.2 ± 2.0 h. The tissue:plasma enrofloxacin concentration ratios (w/w:w/v) were 0.175 ± 0.08 and 0.47 ± 0.06 for Cmax and AUC, respectively. For ciprofloxacin, these values were 0.55 ± 0.13 and 0.58 ± 0.31, respectively. We concluded that plasma concentrations achieved after 5 mg/kg i.v. are high enough to meet surrogate markers for antibacterial activity (Cmax:MIC ratio, and AUC:MIC ratio) considered effective for most susceptible gram‐negative bacteria. Endometrial tissue concentrations taken from the mares after dosing showed that enrofloxacin and ciprofloxacin both penetrate this tissue adequately after systemic administration and would attain concentrations high enough in the tissue fluids to treat infections of the endometrium caused by susceptible bacteria.Keywords
This publication has 18 references indexed in Scilit:
- Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogsAmerican Journal of Veterinary Research, 2002
- Pharmacokinetics of ciprofloxacin in poniesJournal of Veterinary Pharmacology and Therapeutics, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogsResearch in Veterinary Science, 1993
- Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979–1989Equine Veterinary Journal, 1992
- Review Article: Quinolone Arthropathy—Acute Toxicity to Immature Articular CartilageToxicologic Pathology, 1992
- Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection responseAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics of ciprofloxacin after oral and parenteral administrationAntimicrobial Agents and Chemotherapy, 1985
- Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineAntimicrobial Agents and Chemotherapy, 1985
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978